Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

JK, we seem to be going into another war, instigated by lousy energy/foreign policies, against gangsters of the world like China, Russia, Iran, Afghanistan Taliban, socialist/Marxist democrat Venezuela, you name it, we are up against all that. Our energy policy has driven the oil price beyond USD $80 bbl. and the criminals are getting funding?? The incompetent are funding Ukraine with $14 billion to fend off the Russian invasion while the USA is getting invaded!! No one is going to be paying attention to sociopath/“Moran” Fauci since everyone will be engaged in “survival of the fittest “.

https://rumble.com/vb8pbf-open-borders-makes-you-sick.html

Zyesami (Aviptadil) is a formulation of synthetic human Vasoactive Intestinal Peptide (VIP), which was first discovered in 1970. VIP is known to target the VPAC1 receptor of the alveolar type II (ATII) cell and protect that cell against all manner of injuries, including smoke inhalation, exposure to stomach acid, and exposure to infectious agents. In addition, VIP prevents apoptosis, blocks cytokines, lowers TNFa levels, reverses CD4/CD8 ratio, and reduces cough and dyspnea in nonclinical and clinical studies.

Although first identified in the intestinal tract, VIP is produced throughout the body, primarily concentrated in the lungs. In addition, VIP has been shown in more than hundreds of peer-reviewed studies to have potent anti-inflammatory/anti-cytokine activity in animal models of respiratory distress, acute lung injury, and inflammation says the Company.

Because of its lack of toxicity and low cost of manufacture compared to proprietary biologics, VIP may be uniquely attractive to those focused on global countermeasures against COVID-19, says the Company.

https://www.precisionvaccinations.com/vaccines/zyesami-aviptadil-therapeutic